Lenalidomide Generic Med
Award Notice Posted
- Solicitation number
- 36C25726N0241
- Agency
-
Veterans Integrated Service Network 17
Veterans Health Administration, Department of Veterans Affairs
- Awarded
- to Exelan Pharmaceuticals Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36F79720D0227-36C25726N0241 Federal contract award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Big Spring, Texas 79720, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded contract 36F79720D0227 to Exelan Pharmaceuticals Inc. for $899,347.26 on February 5, 2026, to establish a reliable and continuous supply of lenalidomide, an oral immunomodulatory medication used to treat multiple myeloma, anemia in myelodysplastic syndromes, and certain types of lymphoma. The contract will supply multiple strengths of lenalidomide capsules ranging from 2.5mg to 25mg in various package counts to the West Texas VA Health Care System, which serves approximately 50 patients with active prescriptions for the medication. The procurement was conducted as a limited source acquisition under FAR Part 8.405-6 due to lenalidomide's restricted distribution through the FDA-mandated Lenalidomide Risk Evaluation and Mitigation Strategy (REMS) program, which restricts dispensing to only certified prescribers and pharmacies. The contract term extends from the award date through September 30, 2026, and represents the third delivery order awarded to Exelan Pharmaceuticals following previous awards in October 2025.
Notice text
Lenalidomide is an oral immunomodulatory medication that treats several types of blood cancers. The purpose of this contract is to establish a reliable and continuous supply of lenalidomide primarily used to treat multiple myeloma, anemia in myelodysplastic syndromes, and certain types of lymphoma.
Awarded contract 36F79720D0227 to EXELAN PHARMACEUTICALS INC for 899347.26 on 2026-02-05.
Files
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity